Istituto San Raffaele — Clinical Trial Site

30 Registered trials

10 Currently recruiting

Organisation

Istituto San Raffaele

Location

Milan, Italy

Identifier

ORG-100031448

Address

Via Stamira D'ancona 20, 20127, Italy

Departments

#3658:Unità Cardio Metabolica e Trials Clinici
3658: Unità Cardio Metabolica e Trials Clinici
Centro Disturbi dell'Umore
Centro Disturbi dell’Umore
Division of Experimental Oncology
Divisione di Oncologia Sperimentale-Neoplasie Linfocitarie B
General Medicine, Diabetes & Endocrinology
Ginecologia e Ostetricia - IRCCS Ospedale San Raffaele, Milano
Infectious Diseases
Medical Oncology
Oncologia Medica
Oncology Unit
Ospedale San Raffaele (San Raffaele Turro)
Ospedale San Raffaele Turro
Pancreas Translational and Clinical Research Center
Radiology
Rheumatology Unit
U. O. di Ematologia e Trapianto Midollo Osseo (UTMO)
U.O.C. Oncologia Medica
Unità di Gastroenterologia e Endoscopia Digestiva
Unità di Oncologia Medica
Unità Radioterapia
UO Neurologia
UO Neurologia-Centro di Medicina del Sonno
Via Olgettina, 60, Urologia, Milano, 20132, IT

Clinical trials at this site (30)

Search interface

A Study of Disitamab Vedotin Alone and with Pembrolizumab in Urothelial Cancer That Expresses HER2 Not authorised

2022-500030-28-00 Urothelial carcinoma 4
A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE Not authorised

2024-514794-22-01 Eosinophilic granulomatosis with polyangiitis (EGPA) 4
A randomized phase III trial of short-course versus long-course pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III … Pending

2024-519031-42-00 pancreatic ductal adenocarcinoma 5
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending

2024-520326-11-00 Acute Myeloid Leukemia (AML) 4
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending

2025-523911-13-00 Narcolepsy Type 1 5
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 Pending

2025-523912-35-00 Narcolepsy Type 2 5
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
A clinical study of MK-1084 with other treatments for non-small cell lung cancer (MK-3475-01F) Recruiting

2024-512248-47-00 Non-small Cell Lung Cancer (NSCLC) 9 2026-04-15
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Recruiting

2024-519822-18-00 Narcolepsy Type 1, Type 2 and Idiopathic Hypersomnia 10 2025-05-14
MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The M… Recruiting

2024-516841-38-00 recurrent ovarian cancer wild type for germline and som 4 2025-01-09
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A Recruiting

2023-507348-35-00 Risk for Type 1 Diabetes 6 2024-05-30
A Master rollover study to provide continued access to, and assess, long term safety of the study drugs. Recruiting

2023-506330-73-00 Advanced (unresectable or metastatic) human epidermal g 5 2024-03-13
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (… Recruiting

2023-507367-18-00 Pancreatic exocrine insufficiency 6 2024-02-14
ExclUsive endocRine therapy Or radiation theraPy for women aged ≥70 years with luminal A-like early stage breast cancer (EUROPA): a randomiz… Recruiting

2023-508094-88-00 breast cancer 5 2021-02-08
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia Ended

2025-520981-23-00 Idiopathic Hypersomnia (IH) 4 2025-08-26
Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With HR+/HER2− Metastatic Breast Cancer Who Have Received … Ended

2022-502593-17-00 Locally advanced or metastatic hormone receptor (HR)-po 5 2023-09-19
A multi-center Phase 2 study of neoadjuvant immunotherapy in combination with the anti-GDF-15 antibody visugromab (CTL-002) for the treatmen… Ended

2024-513957-55-00 Muscle invasive bladder cancer set to undergo radical c 4 2023-07-21
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
A study of androgen deprivation therapy (ADT) plus apalutamide in patients with prostate cancer Ended

2023-506153-38-00 High-risk localized or locally advanced prostate cancer 5 2019-07-11
A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP 196 in Combination with Obi… Ended

2023-509348-84-00 Chronic Lymphocytic Leukemia 5 2015-04-27
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 Ended

2024-515452-20-00 Narcolepsy Type 2 4 2025-04-01
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 Ended

2024-511112-24-00 Narcolepsy Type 1 4 2025-01-17